Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for HLSQ.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 28.49M
March 31, 2026 6.551M
December 31, 2025 70.24M
September 30, 2025 26.17M
June 30, 2025 38.05M
March 31, 2025 45.65M
December 31, 2024 98.81M
September 30, 2024 59.98M
June 30, 2024 68.62M
March 31, 2024 81.61M
December 31, 2023 58.16M
September 30, 2023 33.06M
June 30, 2023 41.25M
March 31, 2023 41.41M
December 31, 2022 74.45M
September 30, 2022 51.90M
Date Value
June 30, 2022 58.38M
March 31, 2022 68.74M
December 31, 2021 77.99M
September 30, 2021 81.80M
June 30, 2021 61.65M
March 31, 2021 67.06M
December 31, 2020 70.36M
September 30, 2020 75.15M
June 30, 2020 78.31M
March 31, 2020 84.46M
December 31, 2019 92.12M
September 30, 2019 37.62M
June 30, 2019
March 31, 2019 71.35M
December 31, 2018 45.33M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Agenus, Inc. 172.69M
Amgen, Inc. 95.64B
Anika Therapeutics, Inc. 183.47M
BioCryst Pharmaceuticals, Inc. 557.85M
Imunon, Inc. 14.99M

Total Assets (Quarterly) Related Metrics